4//SEC Filing
GOODMAN JONATHAN R. 4
Accession 0001104659-22-120875
CIK 0001811764other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:54 PM ET
Size
4.8 KB
Accession
0001104659-22-120875
Insider Transaction Report
Form 4
GOODMAN JONATHAN R.
Director
Transactions
- Purchase
Common Stock
2022-11-18$6.33/sh+6,000$37,980→ 41,872 total(indirect: Long Zone Holdings, Inc.)
Footnotes (1)
- [F1]A corporation controlled by the Reporting Person.
Documents
Issuer
POINT Biopharma Global Inc.
CIK 0001811764
Entity typeother
Related Parties
1- filerCIK 0001868590
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:54 PM ET
- Size
- 4.8 KB